您的位置:
刘绪强

3276

1.个人信息(Personals

  男,1991.6.19,河南大学校聘副教授。Tel:15060838205

2.受教育经历 (Educational Experience)

  2014/09–2020/07,华侨大学,生物医学材料 博士

  2010/09–2014/07,河南大学,药物制剂   学士

3.工作经历(Professional Experience)

  2022/07–至今,   河南大学,校聘副教授

2020/07–2022/07, 河南大学,师资博士后

4.研究兴趣(Research Interests

(1)药食同源资源功能成分提取、分离、鉴定

(2)药食同源资源的“谱效关联性分析”、“网络药理学”分析等

(3)药食同源资源的抗氧化、抗炎和代谢性疾病的作用机制


5.承担项目情况(Financial Supports)

[1]科技部,国家重点研发计划,典型天然植物化合物绿色制造关键技术研究,2022-12至2026-12,在研,参与

[2]河南省科技厅,河南省重点研发计划,植物源食品功能配料精准营养研发关键技术及应用,2024-01至2025-12,在研,参与

[3]河南省科技厅,河南省科技攻关,基于“谱效关联性分析”结合“分子对接”的栀子降脂、降糖活性成分及机制快速挖掘技术体系,2024-01至2025-12,结项,主持

[4]河南省科技厅,河南省科技攻关项目,“谱效关联性分析”结合“药物分子对接”技术探究中药鹅掌柴抗肝细胞肝癌的活性成分及机制,2021-01至2022-12,结项,主持

[5]河南省人力资源与社会保障厅,河南省博士后科学基金,2022,鹅掌柴三萜类化学成分抗肝细胞癌作用及机制研究,2022-10至2024-10,结项,主持

[6]河南省人力资源与社会保障厅,河南省博士后科学基金,2020,栀子降高尿酸“谱效关系-敲出技术-高分辨质谱-药效”功效成分群快速识别技术研究,2020-7至2022-7,结项,主持

[7]河南省科技厅,河南省科技研发计划联合基金(课题),基于新功能靶点调控蛋白挖掘的豫产中药材护肤功效成分关键技术,2023-10至2026-10,在研,主持


6.代表性论著(Publications)

 期刊论文(Journal Articles)

[1]Xuqiang Liu, Xinjing Meng, Dongqi Liu, Junshang Liu, Mengqi Lan, Wenyi Kang*. A rapid

analysis method to discover antioxidant active components and mechanisms in soybean: untargeted metabolomics combined with network pharmacology and spectrum-effect relationship-component knockout-identification techniques, Food Science and Human Wellness, 2025, 14(9): 3753-3763(共同第一作者)

[2]Mengjie Liu, Xuqiang Liu*, Kaiyue He, Yongping Jian, Yujia Li, Jinrong Guo, Jingyu Yang,

Zhixiang Xu*, Wenyi Kang*. 3-Epi-betulinic acid 3-O-β-D-glucopyranoside (eBAG) induces autophagy by activation of AMP-activated protein kinase in hepatocellular carcinoma, Food Science and Human Wellness, 2024, 13(3): 1453-1464(共同第一作者,共同通讯作者)

[3]Xuqiang Liu, Senye Wang, Lili Cui, Huihui Zhou, Yuhang Liu, Lijun Meng, Sitan Chen, Xuefeng Xi*, Yan Zhang*, Wenyi Kang*. Flowers: precious food and medicine resources. Food Science and Human Wellness. 2023, 12(4):c1020-1052(第一作者)

[4]Xuqiang Liu, Nan Jiang, Cunyu Liu, Zhenhua Liu*, Yan Zhang*, Wenyi Kang*. Anti-Hepatoma Compound Determination by the Method of Spectrum Effect Relationship, Component Knock-Out, and UPLC-MS2 in Scheflera heptaphylla (L.)Frodin Harms and Its Mechanism, Frontiers in Pharmacology, 2020, 11(第一作者)

[5]Xuqiang Liu, Wenjing Shao, Xiaopeng Liu, Yu Zhang, Hui Liu, Jinmei Wang*, Changyang Ma*. Protective effects of Pleurotus placentodes against liver injury in mice via the PTGS2, NR3C1 and PPARA signaling pathways, Journal of Functional Foods, 2024, 122(共同第一作者)

[6]Zhenhua Liang, Yadan Zhang, Jie Li, Yali Liu, Juntao Liu, Chao Zhao, Xuqiang Liu*, Changyang Ma*, Wenyi Kang*. Crocetin, the Key Hypoglycemic Agent in Gardenia jasminoides Identified by Spectrum-Effect Relationship, Targets GRK5 to Activate AKT2 and Improve Glucose Homeostasis, Food Science and Human Wellness, 2026(共同通讯作者)

[7]Xuqiang Liu, Changyang Ma, Zhenhua Liu*, Wenyi Kang*. Natural Products: Review for Their Effects of Anti-HBV[J]. BioMed Research International, 2020, 74: 1-24.(第一作者)

[8]Xuqiang Liu, Yun Niu, Jieqing Liu, Mengjun Shi, Ruian Xu*, Wenyi Kang*. Efficient extraction of anti-inflammatory active ingredients from Schefflera octophylla leaves using ionic liquid-based ultrasonic-assisted extraction coupled with HPLC. Molecules, 2019, 24, 2942.(第一作者)

[9]Xuqiang Liu, jing Dong, Zhenhua Liu*, Ruian Xu*, Wenyi Kang*. Coagulant Effects and Mechanism of Schefflera heptaphylla (L.) Frodin. Molecules, 2019, 24, 4547.(第一作者)

[10]Yan Zhang, Pin Lv, Junmei Ma, Ning Chen, Huishan Guo,Yan Chen, Xiaoruo Gan, Rong Wang, Xuqiang Liu, Sufang Fan,Bin Cong*, Wenyi Kang*, Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo. Acta Pharmaceutica Sinica B, 2022, 12: 890-906.


 专利(Patents

[1]许瑞安,刘绪强,康文艺,姜楠,成文昭,崔秀灵。一种从鹅掌柴叶中提取的化合物及其应用,2021-10-08,中国,CN201911076345.4

[2]康文艺,许瑞安,牛云,刘绪强。利用离子液体从鹅掌柴叶中提取三萜类化合物的方法,2021-04-20,中国,CN201810851639.9

[3]康文艺,张岩,马常阳,刘小朋,刘振花,崔丽丽,刘绪强。一种粗毛纤孔菌多糖及其制备方法和在制备免疫调节药物中的应用,2025-07-11,中国,CN202311003571.6

[4]康文艺,王磊,刘绪强,刘铭,刘振花。染料木素在制备保肝药物方面的应用,2024-04-28,中国,CN202410518882.4

[5]康文艺,张于,刘振花,马常阳,刘绪强,陈宜笑。STBD1蛋白在制备炎症防治药物中的应用,2024-07-09,中国,CN202410915522.8

[6]马常阳,刘振花,康文艺,张于,刘绪强,陈晓宇,陈宜笑。败酱属环烯醚萜类化合物在制备抗炎药物方面的应用,2024-05-15,中国,CN202410601308.5


奖励情况(Awards & Honors

[1]刘绪强(10/10)功能性食品资源综合挖掘与开发利用,河南省科学技术进步奖 二等奖,2023

[2]刘绪强(1/8)第二届河南省博士后创新创业大赛银奖,河南省人力资源与社会保障厅,2024

[3]刘绪强(8/10)食用菌精深加工、种植与综合利用,中国商业联合会特等奖,2022


社会任职(Social Positions):

[1] 《药食同源(英文)》(Food & Medicine Homology, FMH)期刊Managing editor

[2] Journal of future foods, Frontiers in Nutrition等期刊审稿人。



上一篇:刘丽军
下一篇:陈晓宇